Variant report
Variant | nsv561976 |
---|---|
Chromosome Location | chr13:65339575-65353103 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:69004648..69007002-chr13:65338136..65340765,2 | MCF-7 | breast: |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AL445989.1-22 | chr13:65347840-65347902 | NONHSAT034192 |
2 | lnc-AL445989.1-22 | chr13:65349990-65350352 | NONHSAT034192 |
3 | lnc-AL445989.1-22 | chr13:65347836-65347902 | l_866_chr13:65338173-65350330_testes |
4 | lnc-AL445989.1-22 | chr13:65349990-65350330 | l_866_chr13:65338173-65350330_testes |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000127314 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9540213 | chr13:65339575-65339576 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs558569444 | chr13:65339599-65339600 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs562524182 | chr13:65339607-65339608 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs531632876 | chr13:65339625-65339626 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs558504139 | chr13:65339653-65339654 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs562060188 | chr13:65339656-65339657 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs151156712 | chr13:65339738-65339739 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs578028069 | chr13:65339798-65339799 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs200076388 | chr13:65339800-65339801 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs544304128 | chr13:65339847-65339848 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs547680687 | chr13:65339891-65339892 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs595704 | chr13:65339930-65339931 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs187335334 | chr13:65340001-65340002 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs550523235 | chr13:65340073-65340074 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs557380058 | chr13:65340143-65340144 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs568853954 | chr13:65340158-65340159 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs117498525 | chr13:65340176-65340177 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs149875099 | chr13:65340190-65340191 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs191742961 | chr13:65340288-65340289 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs533929490 | chr13:65340348-65340349 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs145427301 | chr13:65340349-65340350 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs141408434 | chr13:65340351-65340352 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs545680367 | chr13:65340372-65340373 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs66481224 | chr13:65340421-65340422 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs184005702 | chr13:65340433-65340434 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs145148609 | chr13:65340510-65340511 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs541858616 | chr13:65340576-65340577 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs376138115 | chr13:65340605-65340606 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs368068104 | chr13:65340638-65340639 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs189997140 | chr13:65340680-65340681 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs73198494 | chr13:65340729-65340730 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs370598607 | chr13:65340748-65340749 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs569444489 | chr13:65340753-65340754 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs560000100 | chr13:65340765-65340766 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs543049666 | chr13:65340789-65340790 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181699523 | chr13:65340822-65340823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs138972957 | chr13:65340841-65340842 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs140643479 | chr13:65340846-65340847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570366658 | chr13:65340849-65340850 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73496519 | chr13:65340852-65340853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs58987411 | chr13:65340898-65340899 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs545878130 | chr13:65340917-65340918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535268981 | chr13:65340974-65340975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533631714 | chr13:65340993-65340994 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs76795583 | chr13:65341049-65341050 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564510386 | chr13:65341060-65341061 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549983652 | chr13:65341067-65341068 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs570280209 | chr13:65341112-65341113 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs539267660 | chr13:65341129-65341130 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185616201 | chr13:65341164-65341165 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:65333400-65341200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
2 | chr13:65333600-65341000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
3 | chr13:65333800-65340200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
4 | chr13:65340000-65341800 | Enhancers | HUVEC | blood vessel |
5 | chr13:65340200-65340400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr13:65340400-65340800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
7 | chr13:65340800-65341600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr13:65340800-65341800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr13:65341000-65341600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr13:65341200-65341600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr13:65341200-65341600 | Enhancers | H1 Cell Line | embryonic stem cell |
12 | chr13:65341200-65341600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr13:65341800-65343400 | Weak transcription | HUVEC | blood vessel |
14 | chr13:65343400-65344200 | Enhancers | HUVEC | blood vessel |
15 | chr13:65351200-65353200 | Enhancers | HUVEC | blood vessel |
16 | chr13:65352200-65352600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |